Comorbidities in Chronic Kidney Disease (CKD)

• Ētahi atu kaituhi: Jankowski, Joachim (Editor), Noels, Heidi (Editor)
• Hōputu: Tāhiko Wāhanga pukapuka
• Reo: Ingarihi
• I whakaputaina: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
• Ngā marau: Medicine; arterial stiffness; carotid-femoral pulse wave velocity; hemodialysis; p-cresyl sulfate; uremic toxins; arterial calcification; lipid metabolism; inflammation; coagulation; endothelial dysfunction; epigenetics; chronic kidney disease; uremic cardiopathy; left ventricular hypertrophy; phosphate; PTH; FGF23; klotho; sclerostin; chronodisruption; chronodisruptor; circadian rhythm; internal clock; uremia; uremic cardiomyopathy; organ crosstalk; cardiorenal syndrome; left-ventricular hypertrophy; heart failure; cardiac fibrosis; cardiovascular disease; vascular calcification; experimental rodent models; FGFG23; Klotho; Wnt/β-catenin; CKD; parathyroid hormone; secondary hyperparathyroidism; uremic toxin; ageing; end-stage kidney disease; premature ageing; senescence; bone; gut; cardiovascular; CKD-MBD; comorbidity; fibrosis; calcification
• Urunga tuihono: DOAB: download the publication; DOAB: description of the publication

With a mean worldwide prevalence of 13%, chronic kidney disease imposes a massive health burden on our society. In addition to reduced kidney function, patients with chronic kidney disease increasingly suffer from cardiovascular diseases affecting the heart and vasculature. Cardiovascular diseases a...